- Product Details
Keywords
- ACT129968
- KYTH-105
- biopharmaleader
Quick Details
- ProName: Setipiprant
- CasNo: 866460-33-5
- Molecular Formula: C24H19FN2O3
- Appearance: solid
- Application: Lab research
- DeliveryTime: 2-3 working days
- PackAge: as per customer's requiremnet
- Port: Shanghai
- ProductionCapacity: Metric Ton/Day
- Purity: 98%min
- Storage: -20℃
- Transportation: as per customer's requiremnet
- LimitNum: 1 Gram
Superiority
Have Kg scale in stock
Details
Setipiprant (ACT-129,968, KYTH-105) is a drug acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients, it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.